SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending following a strong earnings report and positive guidance, with community members actively discussing the potential for a short squeeze and future partnerships with hyperscalers. Talk centers around the company's role in AI infrastructure and potential for significant growth. Some investors are warning of overbought conditions and the risks of algorithmic selling, while others remain extremely bullish, citing the company's long-term potential.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ (LAES) is trending due to its partnership to develop quantum-resistant chips for U.S. defense, fueling speculation about government contracts. The community is discussing its potential for significant growth and comparing it favorably to other quantum stocks. Many believe LAES is undervalued and poised for a substantial run, possibly reaching double digits soon.

One and one Green Technologies. Inc - Ordinary Shares - Class A

YDDL is trending due to its recent IPO and subsequent after-hours surge, fueled by its low float and significant insider ownership. Community members are discussing potential for continued momentum and comparing it to other AI and low-float stocks, while also noting its association with waste management in the Philippines. Traders are watching for potential scalping opportunities, halt patterns, and VWAP reclaims.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is surging amid excitement around its AI automation capabilities and strategic partnerships, drawing comparisons to Palantir's early growth. Community members are closely watching for a potential breakout, fueled by high call option volume and short squeeze potential. The stock's momentum is attracting attention as a key player in the AI infrastructure wave.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf ($WULF) is trending as investors discuss its potential for a short squeeze, fueled by high short interest and recent institutional investment. Community members are also excited about the company's vision and potential connection to clean-energy nuclear reactors for AI infrastructure. The stock is gaining attention as discussions around TeraWulf's pivot towards AI and high-performance computing data centers intensifies, with some comparing it to sector peers.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending as chatter increases about its merger with Infleqtion, a quantum computing company, with comparisons being drawn to sector peers like $NVDA. Community members highlight Infleqtion's existing government contracts and potential for growth, viewing the stock as undervalued relative to competitors and pointing to a potential 10X run. Discussions also include the warrants ($CCCXW) as a means for maximizing potential gains.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as community members debate whether its valuation is justified amidst a significant rally, with some pointing to the potential for a short squeeze and others warning of an impending correction. Bullish sentiment focuses on the future of quantum computing, while bears highlight the company's current financials and question its high market capitalization. Some traders are closely watching for a potential offering, believing it could impact the stock's trajectory.

Yunhong Green CTI Ltd. engages in development, production, and distribution of film products. Its products include Novelty Products and Flexible Films. The Novelty Products consist principally of foil and latex balloons and related gift items. The Flexible Films Products include food and other commercial and packaging applications. The firm also offers Foil Balloons, Latex Balloons, Packaging Films and Custom Film Products, and Other Products. It operates through the United States and Mexico geographical segments. The company was founded on October 14, 1983 and is headquartered in Lake Barrington, IL.

Yunhong Green CTI Ltd

Yunhong CTI Ltd

Yunhong CTI (YHGJ) is trending due to its after-hours activity and inclusion on Franky's Watchlist, which highlights stocks with high-potential setups. Community members are monitoring premarket volume, VWAP holds, and prior high-of-day retests, while also noting buy signals. The stock's low float and potential for a significant move are also driving interest.

Eightco Holdings, Inc. is a publicly traded holding company, which operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology, and capital solutions to empower small to medium-sized businesses. It operates through the North America and Europe geographical segments. The company was founded in 1966 and is headquartered in Easton, PA.

Eightco Holdings Inc

ORBS is trending as traders discuss recent price volatility and potential catalysts. Community members are debating whether the stock's pullback presents a buying opportunity, while also speculating about news related to Worldcoin and upcoming events involving Dan Ives. Some traders suggest a potential squeeze given the small float, while others express concern about potential dilution.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

GSR III Acquisition Corp. - Ordinary Shares- Class A

GSR III Acquisition Corp. Ordinary Shares

GSRT (soon to be NKLR) is trending as the ticker change approaches, sparking excitement among investors eager to capitalize on the burgeoning nuclear micro-reactor sector. Community members are drawing comparisons to OKLO and anticipating a potential surge, fueled by the increasing demand for scalable, clean energy solutions and the nuclear sector's increasing relevance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Think Rapt Therapeutics (RAPT) Could Surge 101.02%: Read This Before Placing a Bet

The consensus price target hints at a 101% upside potential for Rapt Therapeutics (RAPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Wall Street Analysts Believe Rapt Therapeutics (RAPT) Could Rally 122.22%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 122.2% in Rapt Therapeutics (RAPT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why

Rapt Therapeutics (RAPT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Best Momentum Stocks to Buy for July 15th

FUTU, IVZ and RAPT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 15, 2025.

Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect?

The consensus price target hints at an 183.8% upside potential for Rapt Therapeutics (RAPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

New Strong Buy Stocks for July 15th

FUTU, PAAS, RAPT, HG and IVZ have been added to the Zacks Rank #1 (Strong Buy) List on July 15, 2025.

Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's  What You Should Know

Clear Street initiated coverage of Rapt Therapeutics with a Buy rating and set a $3 price target, as the research firm has “strong conviction” in RPT904b as the company's candidate for the treatment of food allergy and chronic spontaneous urticaria (CSU).Shares of Rapt Therapeutics closed flat at $1.02 on Thursday, but rose 7.8% to $1.10 in after-hours trading.Clear Street said that RPT904b represents a "potentially best-in-class anti-IgE antibody" that rivals Xolair, the treatment jointly offered by Roche and Novartis.The firm also noted that Rapt shares have declined 76% over the past 12 months, compared to a 12% drop in the XBI biotech ETF, attributing the drop to an unrelated asset discontinuation.&nbsp;According to Clear Street, this has created a "significant opportunity" for investors.According to Rapt Therapeutics, RPT904b is a half-life extended monoclonal antibody designed to bind free human IgE, a central player in allergic inflammatory diseases.&nbsp;In early-stage trials, the candidate has shown extended pharmacokinetics and pharmacodynamics relative to Xolair, potentially enabling dosing every 8 to 12 weeks, compared to 2 to 4 weeks for omalizumab.&nbsp;It also aims to treat patients with high IgE levels or body weights who may not qualify for existing anti-IgE therapies.On May 22, UBS reduced its price target for Rapt Therapeutics to $1 from $2, while keeping its ‘Neutral’ rating unchanged.&nbsp;The research note from UBS said that the in-licensing of RPT904 as an omalizumab "bio-better" stands as a principal long-term asset for Rapt.UBS raised concerns about the short-term visibility of the addressable market but acknowledged that, although food allergy represents significant commercial potential, identifying the specific patient group in which RPT904 will show meaningful clinical results remains challenging.Meanwhile, H.C. Wainwright launched coverage for Rapt with a ‘Buy’ rating and established a $6 price target on the same day.&nbsp;The research firm highlighted RPT904 as an IgE blocker that follows a commercially validated approach to minimize target risk, referencing the proven effectiveness of omalizumab in treating food allergy, as well as asthma and chronic spontaneous urticaria cases.On Stocktwits, retail sentiment was ‘bearish’ amid ‘low’ message volume.A user expressed worries about the biotech’s cash runway.<stembedurl>https://stocktwits.com/Disrupter/message/617013073</stembedurl>The stock has declined 37.4% so far in 2025.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position

Clear Street’s initiated with a $3 price target, highlighting RPT904b as a “potentially best-in-class anti-IgE antibody.”

Equity

Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

RAPT Therapeutics Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

RAPT
RAPT Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RAPT News

RAPTRAPT Therapeutics Inc